Evidence map›Paper›PMID 38910182›Full record

Observational studyScientific reports2024

Assessing the relationship between lipoprotein(a) levels and blood pressure among hypertensive patients beyond conventional measures. An observational study.

Nestor Vazquez-Agra, Anton Cruces-Sande, Sofia Barbosa-Gouveia, Jose-Enrique Lopez-Paz, Miguel Camafort, Emilio Casariego-Vales, Antonio Pose-Reino, Alvaro Hermida-Ameijeiras

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06325800 (Multimodal Vascular Phenotyping and Target-Organ Damage Using Vascular Imaging, Glyco-Oxidative Biomarkers, and Photoplethysmography in Adults at Increased Cardiovascular Risk), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06325800 recruitingnot on this map

Multimodal Vascular Phenotyping and Target-Organ Damage Using Vascular Imaging, Glyco-Oxidative Biomarkers, and Photoplethysmography in Adults at Increased Cardiovascular Risk: The GlycOxiTOD Observational Registry

Typeobservational_patient_registrySponsorComplejo Hospitalario Universitario de SantiagoRan2024 to 2035Enrolled1,000ConditionsHypertension, Target Organ Damage, Heart Disease Risk Factors, Vascular StiffnessArmsMultimodal Cardiovascular Phenotyping
3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Effects of aged black garlic (ABG10+Frontiers in nutrition · 2026
    Trial
  2. Article
  3. Article
  4. Lipoprotein(a) in Essential Hypertension: Associations with Blood Pressure and Hypertension-Mediated Organ Damage.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026
    Observational
  5. Article
  6. Observational
  7. Article
  8. Lipoprotein(a) and panvascular disease.Lipids in health and disease · 2025
    Review
  9. Article
  10. Lipoprotein(a) among normotensive patients and risk of incident hypertension.Journal of clinical hypertension (Greenwich, Conn.) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nestor Vazquez-AgraDepartment of Internal Medicine, University Hospital of Santiago de Compostela, A Choupana Street, 15706, Santiago de Compostela, A Coruña, Spain. nestor.vazquez.agra@sergas.es.
Anton Cruces-SandeHealth Research Institute of Santiago de Compostela (IDIS), A Choupana Street, 15706, Santiago de Compostela, A Coruña, Spain. anton.cruces@usc.es.
Sofia Barbosa-GouveiaHealth Research Institute of Santiago de Compostela (IDIS), A Choupana Street, 15706, Santiago de Compostela, A Coruña, Spain. sofia.bsg@gmail.com.
Jose-Enrique Lopez-PazDepartment of Internal Medicine, University Hospital of Santiago de Compostela, A Choupana Street, 15706, Santiago de Compostela, A Coruña, Spain.
Miguel CamafortDepartment of Internal Medicine, Hospital Clinic de Barcelona, 08036, Barcelona, Spain.
Emilio Casariego-ValesDepartment of Internal Medicine, University Hospital of Santiago de Compostela, A Choupana Street, 15706, Santiago de Compostela, A Coruña, Spain.
Antonio Pose-Reino *Department of Internal Medicine, University Hospital of Santiago de Compostela, A Choupana Street, 15706, Santiago de Compostela, A Coruña, Spain.
Alvaro Hermida-Ameijeiras *Department of Internal Medicine, University Hospital of Santiago de Compostela, A Choupana Street, 15706, Santiago de Compostela, A Coruña, Spain.

Funding

Río Hortega contract, Carlos III Health Institute (ISCIII) CM21/00068
6 · The paper itself

Abstract

High lipoprotein(a) (Lp(a)) levels are associated with an increased risk of arterial hypertension (AHT) and atherosclerotic cardiovascular disease. However, little is known about the detailed profile of AHT based on Lp(a) levels. This observational study focused on elucidating the relationship between Lp(a) concentrations and specific indices obtained from 24-h ambulatory blood pressure (BP) monitoring in hypertensive patients over 18 years of age. We gathered and analyzed data on BP indices along with demographic, epidemiological, clinical, and laboratory variables from 227 hypertensive patients, median age 56 years, including 127 women (56%). After comparing hypertensive patients with Lp(a) levels above and below 125 nmol/L, we found that a 10 mmHg increase in nocturnal systolic BP and all pulse pressure indices (24-h, daytime, and night-time) was associated with an increased risk of high Lp(a) levels by more than 20% and 40%, respectively. Similarly, each 10% increase in the area under the function over time of nocturnal diastolic BP dipping was associated with more than a 30% decrease in the odds of belonging to the elevated Lp(a) levels category. Additionally, Lp(a) levels above 125 nmol/L were associated with higher 24-h, daytime, and night-time systolic BP and pulse pressure load. The relationship between Lp(a) and AHT appears to extend beyond conventional BP measurements, which may be relevant given the prognostic implications of nocturnal BP and pulse pressure indices.

Indexed as

Blood PressureBlood Pressure Monitoring, AmbulatoryHypertensionLipoprotein(a)AdultAgedFemaleHumansMaleMiddle AgedRisk FactorsLipoprotein(a)Blood pressure monitoringHypertensionLipoprotein(a)

Identifiers

PMID38910182
PMCPMC11194270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.